AL
Theraclion S.A.
ALTHE.PA · PAR
0.70 € +1.46% (+0.01 €)
1M +11.29%
Market Cap 31.4M €
P/E Ratio -
Div. Yield -
ROE 715.40%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 15.58x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 17.55%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak Op. margin 548.04%
Gross margin 666.11%
FCF margin 336.60%
Quality
2 /100
Poor ROA 99.12%
ROIC 118.14%
Asset turnover 0.17x
Debt
71 /100
Low Net debt/EBITDA -0.26x
Current ratio 2.40x
Int. coverage -113.76x
Stability
21 /100
Unstable EPS volatility 56.54%
Beta 0.39x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ALTHE.PA
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Martin Deterre
Employees
36
Headquarters
Malakoff
Prihajajoči dogodki
26 OKT.
Earnings
Upcoming earnings report